Publications Office of the EU
Cyprus-Nicosia: General anti-infectives for systemic use and vaccines - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Cyprus-Nicosia: General anti-infectives for systemic use and vaccines

Overview
  • Awarded
    22/10/2021
  • Today
    10/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Υπουργείο Υγείας
Place of performance
NUTS code: CY000 Κύπρος
Location of buyer
NUTS code: CY Κύπρος (Kýpros)
Business sector (Main CPV)
33651000 General anti-infectives for systemic use and vaccines
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
457,600.00 EUR
Procedure details
Tender reference number
Not available
Description

Προσφορά για την προμήθεια Colistimethate Sodium

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
CY000 Κύπρος
CPV code

33651000 - General anti-infectives for systemic use and vaccines

Award method
Lowest price
Estimated value
Not available
Final contracted value
457,600.00 EUR
Award of contract
Official name: M.A. PHARMACEUTICALS TRADING LTD
Postal address: 28ΗΣ ΟΚΤΩΒΡΙΟΥ, ΚΑΝΙΚΑ CENTER B, ΔΙΑΜ. 704
Town: ΛΕΜΕΣΟΣ
Postal code: 3105
Country: CYP
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.